Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ION advanced for three days, in 191 of 217 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
ION may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ION declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Aroon Indicator for ION entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where VALE advanced for three days, in 235 of 313 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 17 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
VALE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VALE as a result. In 46 of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 62%.
The Moving Average Convergence Divergence Histogram (MACD) for VALE turned negative on October 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 29 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 60%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VALE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.
The Aroon Indicator for VALE entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 4 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 37 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.229) is normal, around the industry mean (7.004). P/E Ratio (21.960) is within average values for comparable stocks, (-0.421). Projected Growth (PEG Ratio) (0.294) is also within normal values, averaging (1.026). VALE's Dividend Yield (0.127) is considerably higher than the industry average of (0.015). P/S Ratio (1.464) is also within normal values, averaging (283.864).
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. VALE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 67 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VALE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.
The Tickeron SMR rating for this company is 82 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
VALE | ||
|---|---|---|
OUTLOOK RATING 1..100 | 56 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 37 Fair valued | |
PROFIT vs RISK RATING 1..100 | 67 | |
SMR RATING 1..100 | 82 | |
PRICE GROWTH RATING 1..100 | 63 | |
P/E GROWTH RATING 1..100 | 4 | |
SEASONALITY SCORE 1..100 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| ION | VALE | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 87% | 1 day ago 57% |
| Stochastic ODDS (%) | 1 day ago 79% | 1 day ago 72% |
| Momentum ODDS (%) | N/A | 1 day ago 62% |
| MACD ODDS (%) | N/A | 1 day ago 60% |
| TrendWeek ODDS (%) | 1 day ago 82% | 1 day ago 63% |
| TrendMonth ODDS (%) | 1 day ago 81% | 1 day ago 69% |
| Advances ODDS (%) | 8 days ago 88% | 17 days ago 75% |
| Declines ODDS (%) | 6 days ago 83% | 1 day ago 72% |
| BollingerBands ODDS (%) | 1 day ago 85% | 1 day ago 68% |
| Aroon ODDS (%) | 1 day ago 83% | 1 day ago 67% |
A.I.dvisor tells us that ION and ALB have been poorly correlated (+13% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ION and ALB's prices will move in lockstep.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BBC | 42.81 | 1.03 | +2.47% |
| Virtus Biotech Clinical Trials ETF (BBC) | |||
| GROZ | 32.11 | 0.13 | +0.41% |
| Zacks Focus Growth ETF (GROZ) | |||
| LQDM | 23.04 | N/A | N/A |
| Amplify LQD Investment Grade 12% Target Income ETF (LQDM) | |||
| NZF | 11.25 | -0.01 | -0.09% |
| Nuveen Municipal Credit Income Fund | |||
| HPS | 11.76 | -0.02 | -0.17% |
| John Hancock Preferred Income Fund III | |||